Navigation Links

Biology Technology

HPP Cold-Pressed Fresh Fruit and Vegetable Juices by Vegesentials USA Now Available on

Bloomfield Hills, Michigan (PRWEB) February 27, 2017 Vegesentials, the multiple international award-winning high-pressure pasteurized cold-pressed fruit and vegetable drink brand is now available on . In 2016, the London-based Vegesentials Ltd. partnered with Michigan-based Vegese... [Comments]

Animals in Experimental Research in Europe are Treated With Care

BASEL, Switzerland , February 27, 2017 A Europe-wide survey of institutes conducted by the Basel Declaration Society (BDS) has indicated that researchers using animals in their research treat them with due care. The survey polled a total of 755 researchers from 26 countries, and detailed analysis of the results indicates that there is a strong commitment among animal researc... [Comments]

InMed Receives over $1,350,000 From Warrant Exercise

VANCOUVER , Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), reported today that prior to their expiry on Friday, February 24, 2017 a total of 10,672,750 common share purchase warrants have been exercised at a price of $0.13 per common share. Proceeds from the exercise of these warrants totalled $1,387,458 and 10,672,750 common shares were issued fro... [Comments]

AcelRx Pharmaceuticals' New Drug Application for DSUVIA Accepted for Filing with PDUFA Date of October 12, 2017

REDWOOD CITY, Calif. , Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, announced today the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) under section 505(b)(2)... [Comments]

Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead Pharma, Pacific Biosciences of California, and Conatus Pharma

NEW YORK , February 27, 2017 Four US Biotech equities have been lined up by for evaluation today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), Pacific Biosciences of California Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ). According to an article on ETF Trends, market ob... [Comments]

Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy

PRINCETON, N.J. and HAMILTON, Bermuda , Feb. 27, 2017   Advaxis, Inc. (NASDAQ: ADXS ) and SELLAS Life Sciences Group , both late-stage biopharmaceutical companies focused on developing cancer immunotherapies, today announced that Advaxis has granted SELLAS a license to develop a novel cancer immunotherapy agent using Advaxis' proprietary Lm -based antigen delivery... [Comments]

Fluxion Biosciences Appoints Genetracer Biotech of Spain As an Isoflux Liquid Biopsy Certified Service Provider

SAN FRANCISCO , Feb. 27, 2017 Fluxion Biosciences announced today that Genetracer Biotech of Santander, Spain has been appointed as a Certified Service Provider for Fluxion's IsoFlux CTC Liquid Biopsy System. The IsoFlux system will be used in Genetracer Biotech's novel liquid biopsy workflows for detection of mutations relevant to lung and colon cancer, with plans to move... [Comments]

Iowa Premix Manufacturer Believes College Athletes Make Top Employees

URBANDALE, Iowa (PRWEB) February 27, 2017 In starting a program to hire college athletes, Catalyst COO Jos Zamzow is following the advice of his grandfather, “Hire for attitude. Train for skill.” In keeping with this philosophy, the Catalyst an Iowa premix manufacturer recently hired Iow... [Comments]

Catalyst Feed Mill Certified as Organic

URBANDALE, Iowa (PRWEB) February 27, 2017 The Catalyst Midwest premix manufacturing facility has been certified as organic, becoming one of only a few in the Midwest offering premix services and private label organic services. The first organic product is Organic 18 Percent Layer Feed, a... [Comments]

An upcoming segment of the Rob Lowe-Hosted "Informed" Public Television Series will Discuss Climate Change

(PRWEB) February 26, 2017 Rob Lowe is a well recognized television personality, so it seems natural he would host a public television series. This series, called "Informed," focuses on issues that are important to the American public and important to society at large. An upcoming ep... [Comments]

Verified Clinical Trials and The STARR Coalition Join Forces To Advocate For Mental Health Care

Garden City, New York (PRWEB) February 25, 2017 The STARR Coalition today announced their partnership with Verified Clinical Trials in an ongoing effort to create meaningful change by increasing communication, partnerships and goodwill among stakeholders in the areas of treatment, advocac... [Comments]

Medicine Technology

Clinical Trial Management System Market Worth $2 Billion by 2024: Global Market Insights Inc.

OCEAN VIEW, Delaware , February 27, 2017 The report "(CTMS)  Clinical Trial Management System Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode (Web, Cloud, On Premise), By End Use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers), Industry Analysi... [Comments]

Halyard Health, Inc. Announces Fourth Quarter and Full-Year 2016 Results, Provides 2017 Outlook

ALPHARETTA, Ga., Feb. 27, 2017 Halyard Health, Inc. (NYSE: HYH ) today reported fourth quarter and full-year 2016 results and provided its 2017 outlook and related key planning assumptions. Executive Summary 2016 fourth quarter net sales were $410 million, a 2 percent increase compared to the prior year. Net income for the fourth quarter 2016 was $10 million compared to ne... [Comments]

78% Stroke Reduction with Newer No-Touch Beating Heart Bypass Surgery, According to Landmark Study

NEW YORK , Feb. 27, 2017  A landmark study led by Prof. Michael P. Vallely , MBBS, PhD, FRACS, of  Sydney Heart and Lung Surgeons  and the University of Sydney will be published in the February 28, 2017 issue of the  Journal of the American College of Cardiology . According to the study, which involved 37,720... [Comments]

Landmark Study: Meta-Analysis of 28 Studies Shows Stretta Therapy for GERD Consistently and Significantly Improves Outcomes

NORWALK, Conn. , Feb. 27, 2017 Mederi Therapeutics today announced the publication of a meta-analysis of 28 studies, representing 2468 patients who received  Stretta Therapy  to treat gastroesophageal reflux disease (GERD). The study entitled, " Systematic Review and Meta-Analysis of Controlled and Prospective Cohort Efficacy Studies of Endoscopic Radiofrequency for... [Comments]

Interpace Diagnostics to Present New Data on Thyroid Product Performance

PARSIPPANY, N.J. , Feb. 27, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, announced today the acceptance of four posters to be presented at the upcoming United States and Canadian Academy of Pathology (USCAP) meeting being held March 4-10,... [Comments]

Philips receives FDA 510(k) clearance to market its ElastQ Imaging shear wave elastography for non-invasive assessment of tissue stiffness of the liver

AMSTERDAM , Feb. 27, 2017   Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ElastQ Imaging capability, further expanding the functionalities of its EPIQ family of ultrasound systems. ElastQ Imaging enables simultaneous imaging of tissue and assessm... [Comments]

International Biophysics Announces 34% Revenue Growth for 2016 as it Celebrates 25 Years in the Medical Device Industry.

AUSTIN, Texas , Feb. 27, 2017  International Biophysics Corporation, a global medical device manufacturer based in Austin, Texas , today announced a 34% revenue growth in 2016 when compared to the previous year based upon a 53% increase in unit sales.  This growth was fueled by its AffloVest® sales in the United States in addition to the expansion of its global... [Comments]

Keystone Heart Applauds FDA Advisory Panel for Recognition of The Need for Cerebral Protection Following TAVR

CAESAREA , Israel and TAMPA, Fla. , Feb. 27, 2017 Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, applauds the members of the FDA's Circulatory System Devices Panel that convened this past week for their acknowledgement of the need for cerebral protection follo... [Comments]

New Liposome Technology For Advanced Nutrient Bioavailability Set To Transform The Vitamin Industry

PLACENTIA, Calif. , Feb. 27, 2017   Vitasome ® Labs , Inc. has launched a new line of nutritional supplements using its groundbreaking new liposome technology. Whereas vitamins lose on average between 82 and 90 percent of potency through digestion per Physician's Desk Reference , Vitasome ' s ® nutritional supplements solve the problem of nutritional waste and are scien... [Comments]

Infinity to Present at 37th Annual Cowen and Company Healthcare Conference

CAMBRIDGE, Mass. , Feb. 27, 2017  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) will be presenting at the Cowen and Company 37 th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at , and will be availa... [Comments]

RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137 for Epidermolysis Bullosa in U.S.

ROCKVILLE, Md. , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its licensee for RGN-137, GtreeBNT Co., Ltd., received a positive response from the U.S. FDA for its Phase 3 clinical trial design for RGN-137 to... [Comments]

(Date:2/27/2017)... Fluxion Biosciences announced today that Genetracer Biotech ... appointed as a Certified Service Provider for Fluxion,s IsoFlux ... used in Genetracer Biotech,s novel liquid biopsy workflows for ... with plans to move to other cancers as additional ... System to isolate, recover, and analyze CTCs (circulating tumor ...
(Date:2/25/2017)... New York (PRWEB) , ... February 25, 2017 ... ... partnership with Verified Clinical Trials in an ongoing effort to create ... of treatment, advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
(Date:2/24/2017)... HONG KONG, Feb. 24, 2017 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its unaudited financial results for the ... 2017 ended December 31, 2016. Third Quarter ... the third quarter of fiscal 2017 increased by 18.6% ...
Breaking Biology Technology:
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology: